US Stock MarketDetailed Quotes
VKTX Viking Therapeutics
- 53.420
- +1.430+2.75%
Close Nov 26 16:00 ET
- 53.400
- -0.020-0.04%
Post 20:02 ET
5.95BMarket Cap-56829P/E (TTM)
56.249High52.330Low5.19MVolume55.265Open51.990Pre Close281.41MTurnover4.95%Turnover RatioLossP/E (Static)111.44MShares99.41052wk High6.53P/B5.60BFloat Cap14.02052wk Low--Dividend TTM104.78MShs Float99.410Historical High--Div YieldTTM7.54%Amplitude0.880Historical Low54.248Avg Price1Lot Size
About Viking Therapeutics Company
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660
Company Executives
- Name
- Position
- Salary
- Dr. Brian Lian, PhD
- President, Chief Executive Officer and Director
- 12.63M
- Greg S. Zante
- Chief Financial Officer and Principal Accounting Officer
- 3.50M
- Marianne Mancini
- Chief Operating Officer
- 3.51M
- Charles A. Rowland, Jr,M.B.A.
- Independent Director
- 189.62K
- Matthew W. Foehr
- Independent Director
- 169.37K
- J. Matthew Singleton
- Independent Director
- 192.77K
- Dr. S. Kathryn Rouan, PhD
- Independent Director
- 178.65K
- Dr. Lawson Macartney, D.V.M.,PhD
- Chairperson of the Board
- 222.72K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
